Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 314.00
-14.00 (-4.27%)
At close: Feb 6, 2026
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 10.69 billion as of February 6, 2026. Its market cap has decreased by -38.31% in one year.
Market Cap
10.69B
Enterprise Value
8.58B
Revenue
992.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
314.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 10.69B, a decrease of -54.97%. That is a compound annual growth rate of -15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 10.69B | 54.68% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | 23.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ReproCELL | 15.06B |
| Kubota Pharmaceutical Holdings | 14.43B |
| Immuno-Biological Laboratories | 14.36B |
| Kidswell Bio | 12.30B |
| CellSeed | 10.49B |
| Nano Holdings | 10.47B |
| StemCell Institute | 8.76B |
| K Pharma,Inc. | 8.05B |